Update on Measuring Ketones View AgendaFree Registration

The Update on Measuring Ketones webinar will be held on October 13, 2022 from 9 AM to 10:30 AM Pacific Time.

Now Accepting Applications for the Startup Showcase at Virtual Diabetes Technology Meeting 2022

Click here to learn more. Applications are due by August 31, 2022.

Subscribe

Join the DTS mailing list
and receive updates
delivered to your inbox.

 

News

MEDSCAPE: What Is the Glycemic Risk Index and Why Do We Need It?

UPI: Pacemakers, insulin pumps can be hacked, experts say

HEALIO: Glycemia Risk Index provides new tool for assessing glycemic control with CGM data

HEALIO: Stakeholders challenged to take action at first Green Diabetes Summit

MEDSCAPE: Continuous Ketone Monitoring Has Potential to Cut DKA in Diabetes

DIATRIBE: Glycemia Risk Index – An Emerging Measurement to Complement Your TIR

HEALIO: Connectivity, digital tools becoming the ‘sixth vital sign’ in health care

MEDSCAPE: Wearable Continuous Ketone Monitoring Appears Feasible

HEALIO: Continuous ketone monitoring may provide early identification of DKA

HP ENTERPRISE.NXT: How the edge is reshaping healthcare

MEDSCAPE: Protecting Patients With Diabetes From Impact of COVID-19

ENDOCRINOLOGY ADVISOR: Benefits of Continuous Glucose Monitoring Systems in the Hospital Setting

HEALIO: Telehealth shift during COVID-19 pandemic shows capacity to deliver safe, convenient care

ENDOCRINE NEWS: New App Helps Improve Diabetes Care in Patients with COVID-19

ENDOCRINE NEWS: Pandemic Parallels: Glycemic Control in COVID-19 Patients

MEDSCAPE: Largest Study to Date Links Glucose Control to COVID-19 Outcomes

NEWSDAY: Coronavirus poses special risks for diabetics

HEALIO: Uncontrolled hyperglycemia, diabetes drive longer hospital stay, mortality in COVID-19

ELSEVIER: Diabetes Digital Health (Edited by David Klonoff et al.)

THE WASHINGTON POST: DIY diabetes tech gains popularity with patients and parents fed up with clunky mainstream medical devices

HEALIO: Postoperative infections less frequent with insulin pump therapy for adults with diabetes

THE DIPLOMAT: Cost of Diabetes Reaches $850 Billion a Year Globally

ADA: David Klonoff, MD, President of Diabetes Technology Society, receives an international award from the American Diabetes Association.

We recommend: